Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP380920.RAzA5jT88xIvPhramMyw-ph-n3ZsrzkNfxBmVOdgLlzu4130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP380920.RAzA5jT88xIvPhramMyw-ph-n3ZsrzkNfxBmVOdgLlzu4130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP380920.RAzA5jT88xIvPhramMyw-ph-n3ZsrzkNfxBmVOdgLlzu4130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP380920.RAzA5jT88xIvPhramMyw-ph-n3ZsrzkNfxBmVOdgLlzu4130_provenance.
- NP380920.RAzA5jT88xIvPhramMyw-ph-n3ZsrzkNfxBmVOdgLlzu4130_assertion description "[Our data confirm that downregulating the ErbB3-mediated signals with the use of anti-ErbB3 monoclonal antibodies is both feasible and relevant for therapeutic purposes and provides new opportunities for novel anti-ErbB3 combinatory strategies for cancer treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP380920.RAzA5jT88xIvPhramMyw-ph-n3ZsrzkNfxBmVOdgLlzu4130_provenance.
- NP380920.RAzA5jT88xIvPhramMyw-ph-n3ZsrzkNfxBmVOdgLlzu4130_assertion evidence source_evidence_literature NP380920.RAzA5jT88xIvPhramMyw-ph-n3ZsrzkNfxBmVOdgLlzu4130_provenance.
- NP380920.RAzA5jT88xIvPhramMyw-ph-n3ZsrzkNfxBmVOdgLlzu4130_assertion SIO_000772 22213458 NP380920.RAzA5jT88xIvPhramMyw-ph-n3ZsrzkNfxBmVOdgLlzu4130_provenance.
- NP380920.RAzA5jT88xIvPhramMyw-ph-n3ZsrzkNfxBmVOdgLlzu4130_assertion wasDerivedFrom befree-20150227 NP380920.RAzA5jT88xIvPhramMyw-ph-n3ZsrzkNfxBmVOdgLlzu4130_provenance.
- NP380920.RAzA5jT88xIvPhramMyw-ph-n3ZsrzkNfxBmVOdgLlzu4130_assertion wasGeneratedBy ECO_0000203 NP380920.RAzA5jT88xIvPhramMyw-ph-n3ZsrzkNfxBmVOdgLlzu4130_provenance.
- befree-20150227 importedOn "2015-02-27" NP380920.RAzA5jT88xIvPhramMyw-ph-n3ZsrzkNfxBmVOdgLlzu4130_provenance.